NCT00583531View on ClinicalTrials.gov

Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Pouchitis

Interventions

DRUG

AST-120

Oral, 2 grams TID in sachets for 4 weeks

Trial Locations (1)

55905

Mayo Clinic, Inflammatory Bowel Disease Clinic, Rochester

Sponsors

Lead Sponsor

Ocera Therapeutics

All Listed Sponsors

lead

Ocera Therapeutics

INDUSTRY

NCT00583531 - Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis | Biotech Hunter | Biotech Hunter